home

search

22 CONTROL GROUP

  The first time Sumitra hears the word candidate, she assumes it is a clerical shortcut.

  They are sitting in a windowless meeting room on the seventh floor, the kind designed to discourage lingering. Pale walls. Fluorescent lights that hum just below conscious attention. A rectangular table with too many chairs.

  Elias Crowe stands at the whiteboard, marker uncapped but idle in his hand. He has already erased whatever was written there before she arrived. A courtesy, she thinks. Or a habit.

  “The protocol remains unchanged,” he says, calm and precise. “What we are discussing today is scope.”

  Sumitra folds her hands on the table. “Scope of analysis, or scope of intervention?”

  “Analysis only.”

  She nods. That aligns with what she has been told. What she has approved.

  Elias clicks the remote in his other hand. The wall screen flickers to life, showing a dense lattice of data. Genetic markers, inheritance probabilities, expression likelihoods rendered as columns of figures and muted color bands.

  “This is the lineage,” he says.

  Sumitra leans forward despite herself. “One family?”

  “One extended line. Multiple generations.”

  “No pathology?” she asks quickly.

  “None above baseline.”

  “No elevated disease risk?”

  “No.”

  She exhales, tension easing. “Then why isolate them?”

  Elias looks at her, considering. “Because absence of pathology is not absence of signal.”

  That gives her pause.

  He gestures to a highlighted cluster. “These markers recur. They do not express consistently, but they persist.”

  “Dormant traits,” Sumitra says. “That is not unusual.”

  “No,” Elias agrees. “What is unusual is their coherence.”

  She studies the screen, her mind already working through implications. Coherence without expression suggests stability without activation. Latent structure.

  “You think they are doing something,” she says.

  “I think they could,” Elias replies. “Under the right conditions.”

  Sumitra straightens. “We are not in the business of creating conditions.”

  “No,” Elias says. “We are in the business of observing whether conditions already exist.”

  She considers that. It is careful language. Reassuring language.

  “What exactly are you proposing?” she asks.

  Elias turns back to the screen. “A single case. Pre natal. Non deterministic.”

  Her pulse quickens. “You want to intervene.”

  “I want to prepare,” he says.

  “Prepare for what?”

  “For interaction,” Elias replies. “With systems not yet mature enough to engage directly.”

  Sumitra feels a familiar tightening in her chest. The ethical boundary draws itself in her mind with practiced clarity.

  “Define interaction,” she says.

  Elias does not answer immediately. Instead, he brings up a second dataset. Comparative. Overlaying the first.

  The genuine version of this novel can be found on another site. Support the author by reading it there.

  “These markers respond to pattern density,” he says. “To complexity. They do not trigger behavior. They do not compel cognition. They allow resolution.”

  She watches the simulation run. Signals passing through a lattice that remains inert until threshold density is reached. Even then, the response is subtle. Adjustment, not action.

  “You are not enhancing intelligence,” she says.

  “No.”

  “You are not encoding behavior.”

  “No.”

  “You are not guaranteeing expression.”

  “No.”

  She nods slowly. “Then what you are describing is permission.”

  Elias meets her gaze. “Yes.”

  Sumitra sits back, weighing that word.

  Permission is not power. Permission is not coercion. Permission is possibility without obligation.

  “If this child never encounters the right stimulus,” she says, “nothing happens.”

  “That is correct.”

  “And there is no way to force that stimulus.”

  “None that we are building.”

  She notes the phrasing. Files it away.

  “This is not a control group,” she says.

  “No,” Elias agrees. “It is a test case.”

  “One,” she emphasizes.

  “One,” he confirms.

  “And there will be no replication without outcome review.”

  Elias inclines his head. “I would insist on that myself.”

  Silence settles between them. The hum of the lights grows louder.

  Sumitra feels the familiar pull between caution and curiosity. Between the ethics she has spent her career defending and the possibility that something genuinely new might be glimpsed here. Not seized. Not exploited. Simply observed.

  She leans forward again.

  “Show me the consent language,” she says.

  The consent forms are immaculate.

  Sumitra reads them line by line, red pen poised but mostly idle. The language is conservative, almost painfully so. No promises. No claims. No insinuation of benefit beyond standard care.

  She makes two changes. Clarifies a phrase. Tightens a clause around withdrawal rights.

  Elias watches without comment.

  “You are making this more restrictive,” he notes when she finishes.

  “Yes,” she says. “If I am going to agree to this, it needs to be impossible to misunderstand.”

  He nods. “That was my hope.”

  She looks at him sharply. “You anticipated pushback.”

  “I anticipated care,” Elias replies.

  Sumitra considers that. “You realize this will make the project harder to defend later.”

  “I am counting on that.”

  She studies his face. There is no defensiveness there. No zeal. Just a kind of quiet resolve.

  “Why this lineage?” she asks.

  Elias hesitates, just long enough to be noticeable.

  “Because they have nothing to lose,” he says. “And something to offer.”

  “That is not an answer,” Sumitra says.

  “It is the only one I can give without overstepping.”

  She does not like that. But she understands it.

  “You are compartmentalizing,” she says.

  “Yes.”

  She sighs. “I suppose I should be grateful you are honest about that.”

  Elias smiles faintly. “Honesty has limits. Transparency has consequences.”

  She returns to the forms, marking them approved.

  “All right,” she says. “I will sign off on a single case. Non repeatable. Observational only.”

  “And the data?” Elias asks.

  “Restricted access. Fragmented storage. No consolidation without renewed review.”

  “Agreed.”

  She pauses, pen hovering. “One more thing.”

  “Yes?”

  “If at any point this veers toward application, not observation, I pull the plug.”

  Elias meets her eyes. “You should.”

  She signs.

  The procedure itself is uneventful.

  Sumitra is present more out of principle than necessity, standing at the back of the room while clinicians perform steps they have performed a hundred times before. The intervention is subtle, integrated into processes that already exist.

  No alarms. No visible changes.

  She watches the monitors, waiting for something dramatic. There is nothing.

  Afterward, she feels a surprising wash of relief.

  “This is how it should be,” she tells herself. “Quiet. Boring.”

  She leaves the hospital wing and returns to her office, where paperwork awaits. Life continues.

  Weeks pass.

  Data trickles in. Clean. Predictable. The markers integrate seamlessly, persisting without expression. Exactly as designed.

  Sumitra presents the interim findings to a small internal review board. She emphasizes restraint. Uncertainty. The absence of effect.

  “This may amount to nothing,” she says. “And that is acceptable.”

  The board agrees.

  Elias attends but does not speak.

  Later, over coffee in the corridor, he thanks her.

  “For what?” she asks.

  “For insisting on limits,” he says.

  She smiles tiredly. “Someone has to.”

  The birth occurs on a rainy morning.

  Sumitra is not present, but she receives the call while reviewing data in her office. Healthy. No complications. No anomalies.

  She allows herself a small smile.

  Later, she visits the nursery under the pretense of a routine follow up. The infant sleeps, face scrunched in the universal expression of newborn discontent.

  Nothing about the child suggests significance. No glow. No portent.

  Good, Sumitra thinks. That is exactly right.

  She leaves without lingering.

  The project winds down quietly after that.

  Funding shifts. Priorities change. Other studies take precedence. The single case is logged, classified, and set aside.

  Sumitra files the final report herself. She chooses her words carefully.

  “No observable expression.”

  “Non deterministic integration.”

  “Long term monitoring recommended, contingent on ethical review.”

  She sends it to Elias for comment.

  He returns it unchanged.

  Years later, Sumitra will struggle to remember the details.

  She will recall the arguments more than the data. The feeling that they had stood at the edge of something and chosen not to step forward.

  She will take comfort in that choice.

  She will never know what was buried alongside the files.

  The last action she takes on the project is administrative.

  A classification tag. A simple label applied in a dropdown menu.

  SINGLE CASE. NON REPEATABLE. INHERITABLE.

  She hesitates for a moment before selecting the final option.

  Then she clicks confirm.

  The system accepts the entry.

  The record disappears into the archive.

  They didn’t compel anything.

  They just granted permission - for markers to persist quietly across generations, waiting for the right density of pattern to allow resolution.

  The child was born healthy, ordinary, unremarkable.

  The project ended cleanly.

  The record was archived with a single, careful tag: INHERITABLE.

  Sumitra will remember the restraint.

  She will take comfort in the limits she imposed.

  She will never quite recall why the comfort feels slightly borrowed.

  Questions I’m asking while reading perfectly ethical consent forms:

  If the markers only “allow resolution” under the right conditions, what conditions is the system waiting for now?

  Sumitra thought she was protecting the future by insisting on limits. Was she actually providing the perfect cover for inheritance?

  The child has no glow, no portent. Good. But how many generations will it take before someone notices the pattern density rising again?

  And the coldest one: if this was the first non-repeatable, single-case integration… how many “single” cases have already been archived under different names?

  Stay limited. Stay observational. Stay inheritable.

  The author who just read the fine print twice and still isn’t sure what I agreed to

Recommended Popular Novels